{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:31:37Z","timestamp":1793377897727,"version":"4.5.0"},"reference-count":181,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["819531"],"award-info":[{"award-number":["819531"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101248568"],"award-info":[{"award-number":["101248568"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymthe.2026.07.031","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:34:08Z","timestamp":1784180048000},"page":"5675-5696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Addressing the package: Cell-specific gene delivery using lentiviral vectors"],"prefix":"10.1016","volume":"34","author":[{"given":"Anjali","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix L.","family":"Warnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane W.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2743-0070","authenticated-orcid":false,"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.07.031_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ymthe.2006.03.007","article-title":"Retrovirus Vectors: Toward the Plentivirus?","volume":"13","author":"Baum","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib4","series-title":"Approved Cellular and Gene Therapy Products","first-page":"1","year":"2025"},{"key":"10.1016\/j.ymthe.2026.07.031_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.07.031_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global Manufacturing of CAR T Cell Therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12967-024-06052-3","article-title":"From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy","volume":"23","author":"Pinto","year":"2025","journal-title":"J. translational Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","article-title":"Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery","volume":"33","author":"Buchholz","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib9","doi-asserted-by":"crossref","DOI":"10.5772\/52770","article-title":"Targeted Lentiviral Vectors: Current Applications and Future Potential [Internet]","author":"Goyvaerts","year":"2013","journal-title":"Gene Ther. - Tools Potential Appl."},{"key":"10.1016\/j.ymthe.2026.07.031_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.07.031_bib11","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery","volume":"72","author":"Zufferey","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib12","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1073\/pnas.83.10.3194","article-title":"Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells","volume":"83","author":"Yu","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.031_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa2405541","article-title":"Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy","volume":"391","author":"Duncan","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib14","series-title":"Meta-Analysis and Optimization of the In Vitro Immortalization Assay for Safety Assessment of Retroviral Vectors in Gene Therapy","author":"Bastone","year":"2025"},{"key":"10.1016\/j.ymthe.2026.07.031_bib15","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood-2007-12-128751","article-title":"Resistance of mature T cells to oncogene transformation","volume":"112","author":"Newrzela","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.031_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41375-025-02585-8","article-title":"Current landscape of vector safety and genotoxicity after hematopoietic stem or immune cell gene therapy","volume":"39","author":"Ottaviano","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2026.07.031_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102395","article-title":"Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope","volume":"35","author":"Covo-Vergara","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.031_bib18","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1016\/j.ymthe.2023.08.003","article-title":"CD90-targeted lentiviral vectors for HSC gene therapy","volume":"31","author":"Berckmueller","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-3-69","article-title":"The effects of N-terminal insertion into VSV-G of an scFv peptide","volume":"3","author":"Dreja","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2026.07.031_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.omtm.2021.09.014","article-title":"Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8","volume":"23","author":"Michels","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib21","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41592-022-01436-z","article-title":"Antigen identification and high-throughput interaction mapping by reprogramming viral entry","volume":"19","author":"Dobson","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.07.031_bib23","article-title":"Optimization of the VSV-G backbone for amino terminal fusion with nanobodies allowing its specific retargeting to HER2 receptors","volume":"33","author":"Duqu\u00e9nois","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40788-8","article-title":"Cell type-specific delivery by modular envelope design","volume":"14","author":"Strebinger","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.031_bib25","first-page":"49","article-title":"Viral Expression Cassette Elements to Enhance Transgene Target Specificity and Expression in Gene Therapy","volume":"19","author":"Powell","year":"2015","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.omtm.2018.12.013","article-title":"Transcriptional Targeting and MicroRNA Regulation of Lentiviral Vectors","volume":"12","author":"Merlin","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2014.114","article-title":"Liver-Specific Transcriptional Modules Identified by Genome-Wide In Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates","volume":"22","author":"Chuah","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2008.288","article-title":"MicroRNAs and the Regulation of Vector Tropism","volume":"17","author":"Kelly","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nm1398","article-title":"Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer","volume":"12","author":"Brown","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41434-020-00193-y","article-title":"The stability of envelope-pseudotyped lentiviral vectors","volume":"28","author":"Dautzenberg","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib31","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1073\/pnas.90.17.8033","article-title":"Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells","volume":"90","author":"Burns","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.031_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/v12091016","article-title":"Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy","volume":"12","author":"Gutierrez-Guerrero","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.07.031_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1089\/vim.2004.17.516","article-title":"Vesicular stomatitis virus as an oncolytic vector","volume":"17","author":"Barber","year":"2004","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib34","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1074\/jbc.M708955200","article-title":"Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein","volume":"283","author":"Sun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.07.031_bib35","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s00018-008-7534-3","article-title":"Structures of vesicular stomatitis virus glycoprotein: Membrane fusion revisited","volume":"65","author":"Roche","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2026.07.031_bib36","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14712598.2020.1787981","article-title":"A tool with many applications: vesicular stomatitis virus in research and medicine","volume":"20","author":"Munis","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib37","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.031_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.sbi.2003.10.001","article-title":"The low-density lipoprotein receptor: ligands, debates and lore","volume":"13","author":"Rudenko","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03432-4","article-title":"Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein","volume":"9","author":"Nikolic","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.031_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1135710","article-title":"Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G","volume":"315","author":"Roche","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.07.031_bib41","first-page":"E28","article-title":"Mechanism of membrane fusion induced by vesicular stomatitis virus G protein","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.07.031_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002556","article-title":"Characterization of Monomeric Intermediates during VSV Glycoprotein Structural Transition","volume":"8","author":"Albertini","year":"2012","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.031_bib43","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.ymthe.2025.06.036","article-title":"Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation","volume":"33","author":"Andorko","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib44","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1128\/JVI.02240-13","article-title":"Characteristics of Oncolytic Vesicular Stomatitis Virus Displaying Tumor-Targeting Ligands","volume":"87","author":"Ammayappan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102115","article-title":"Engineering lentivirus envelope VSV-G for liver targeted delivery of IDOL-shRNA to ameliorate hypercholesterolemia and atherosclerosis","volume":"35","author":"Wang","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.031_bib46","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.1128\/JVI.77.23.12807-12818.2003","article-title":"The Membrane-Proximal Region of Vesicular Stomatitis Virus Glycoprotein G Ectodomain Is Critical for Fusion and Virus Infectivity","volume":"77","author":"Jeetendra","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4690-7-3","article-title":"Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma\/leukosis virus","volume":"7","author":"Zhang","year":"2010","journal-title":"Retrovirology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib48","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1128\/JVI.78.10.5079-5087.2004","article-title":"Prediction and Identification of a Permissive Epitope Insertion Site in the Vesicular Stomatitis Virus Glycoprotein","volume":"78","author":"Schlehuber","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jviromet.2008.06.013","article-title":"Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein","volume":"153","author":"Kameyama","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ymthe.2026.07.031_bib50","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.biomaterials.2014.01.051","article-title":"Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein","volume":"35","author":"H\u00f6fig","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2026.07.031_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00372-23","article-title":"Vesicular Stomatitis Virus (VSV) G Glycoprotein Can Be Modified to Create a Her2\/Neu-Targeted VSV That Eliminates Large Implanted Mammary Tumors","volume":"97","author":"Gao","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduction Targeted Therapy"},{"key":"10.1016\/j.ymthe.2026.07.031_bib53","article-title":"Recombinant antibody fragment therapeutics: Current status and future prospects of scFv, nanobody, and mimotopes","volume":"89","author":"Ghaderi","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006292","article-title":"Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering","volume":"11","author":"Michels","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.031_bib55","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1128\/JVI.75.17.8016-8020.2001","article-title":"Antibody-Directed Targeting of Retroviral Vectors via Cell Surface Antigens","volume":"75","author":"Morizono","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01860-17","article-title":"Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types","volume":"8","author":"Kasaraneni","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2026.07.031_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt0897-763","article-title":"Cell-specific targeting of sindbis virus vectors displaying IgG-binding domains of protein a","volume":"15","author":"Ohno","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib58","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4161\/cc.4.7.1789","article-title":"Targeted gene delivery by intravenous injection of retroviral vectors","volume":"4","author":"Morizono","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2026.07.031_bib59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nm1192","article-title":"Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection","volume":"11","author":"Morizono","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib60","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jgm.1345","article-title":"A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide","volume":"11","author":"Morizono","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib61","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12033-016-9973-7","article-title":"Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature","volume":"58","author":"Ahani","year":"2016","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/hum.2005.16.223","article-title":"Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies","volume":"16","author":"Aires Da Silva","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2018.09.017","article-title":"Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules","volume":"525","author":"Situ","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/v14102157","article-title":"Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer","volume":"14","author":"Cordes","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.07.031_bib65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiy565","article-title":"Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans","volume":"219","author":"Poetsch","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.07.031_bib66","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/JVI.00074-14","article-title":"Vesiculovirus Neutralization by Natural IgM and Complement","volume":"88","author":"Tesfay","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib67","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/gt.2013.1","article-title":"Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors","volume":"20","author":"Hwang","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/mt.2009.282","article-title":"Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells","volume":"18","author":"Trobridge","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.omtn.2019.05.010","article-title":"Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery","volume":"17","author":"Munis","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.07.031_bib70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymthe.2004.09.012","article-title":"Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes","volume":"11","author":"van Til","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib71","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1182\/blood-2006-10-049312","article-title":"In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance","volume":"109","author":"Brown","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.031_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.80","article-title":"\u201cMarker of Self\u201d CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors","volume":"3","author":"Sosale","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1039\/D1TB01815A","article-title":"Less phagocytosis of viral vectors by tethering with CD47 ectodomain","volume":"10","author":"Alyami","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ymthe.2026.07.031_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7325","article-title":"Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates","volume":"11","author":"Milani","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/protein\/gzv005","article-title":"Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv","volume":"28","author":"Friedel","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ymthe.2026.07.031_bib76","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1472-6750-13-98","article-title":"Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells","volume":"13","author":"Cribbs","year":"2013","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib77","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtm.2022.06.004","article-title":"In vivo generation of CAR T cells in the presence of human myeloid cells","volume":"26","author":"Ho","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1472-6750-6-34","article-title":"Comparison of lentiviral vector titration methods","volume":"6","author":"Geraerts","year":"2006","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib79","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/vir.0.82221-0","article-title":"Measles virus: Cellular receptors, tropism and pathogenesis","volume":"87","author":"Yanagi","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib80","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.031_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/viro.2000.0711","article-title":"CDw150(SLAM) Is a Receptor for a Lymphotropic Strain of Measles Virus and May Account for the Immunosuppressive Properties of This Virus","volume":"279","author":"Hsu","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/376260a0","article-title":"A novel receptor involved in T\u2013cell activation","volume":"376","author":"Cocks","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.031_bib83","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1357-2725(99)00092-8","article-title":"Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions","volume":"31","author":"Seya","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib84","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/mt.2008.128","article-title":"Targeted cell entry of lentiviral vectors","volume":"16","author":"Funke","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nbt942","article-title":"Antibody-targeted cell fusion","volume":"22","author":"Nakamura","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib86","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1128\/JVI.76.24.13034-13038.2002","article-title":"Identification of a Second Major Site for CD46 Binding in the Hemagglutinin Protein from a Laboratory Strain of Measles Virus (MV): Potential Consequences for Wild-Type MV Infection","volume":"76","author":"Mass\u00e9","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib87","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JVI.78.1.302-313.2004","article-title":"Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model","volume":"78","author":"Vongpunsawad","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005641","article-title":"Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment","volume":"12","author":"Bender","year":"2016","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.031_bib89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/gt.2011.209","article-title":"Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins","volume":"20","author":"Enkirch","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib90","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1182\/blood-2008-05-155945","article-title":"Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins","volume":"112","author":"Frecha","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.031_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/hgtb.2012.054","article-title":"Specific targeting of human interleukin (IL)-13 receptor \u03b12-positive cells with lentiviral vectors displaying IL-13","volume":"23","author":"Ou","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2026.07.031_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079047","article-title":"CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes","volume":"8","author":"Kneissl","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.07.031_bib94","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/hum.2010.184","article-title":"Lentiviral vectors targeted to MHC II are effective in immunization","volume":"22","author":"Ageichik","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib95","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809158","article-title":"In vivo generation of human CD 19- CAR T cells results in B-cell depletion and signs of cytokine release syndrome","volume":"10","author":"Pfeiffer","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib96","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.ymthe.2020.05.005","article-title":"In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes","volume":"28","author":"Agarwal","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib97","first-page":"5702","article-title":"Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors","volume":"4","author":"Frank","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.07.031_bib98","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.ymthe.2025.07.006","article-title":"Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector","volume":"33","author":"Coradin","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02915-2","article-title":"In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles","author":"Botchkarev","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib100","doi-asserted-by":"crossref","first-page":"10155","DOI":"10.1128\/JVI.79.16.10155-10163.2005","article-title":"Envelope Targeting: Hemagglutinin Attachment Specificity Rather than Fusion Protein Cleavage-Activation Restricts Tupaia Paramyxovirus Tropism","volume":"79","author":"Springfeld","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib101","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.omtm.2021.04.012","article-title":"In vivo targeting of lentiviral vectors pseudotyped with the Tupaia paramyxovirus H glycoprotein bearing a cell-specific ligand","volume":"21","author":"Argaw","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jgm.1339","article-title":"Redirecting lentiviral vectors by insertion of integrin-targeting peptides into envelope proteins","volume":"11","author":"Morizono","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib103","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1128\/JVI.74.21.9972-9979.2000","article-title":"The Exceptionally Large Genome of Hendra Virus: Support for Creation of a New Genus within the Family Paramyxoviridae","volume":"74","author":"Wang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib104","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/viro.2000.0340","article-title":"Molecular Characterization of Nipah Virus, a Newly Emergent Paramyxovirus","volume":"271","author":"Harcourt","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1196\/annals.1408.003","article-title":"Molecular characteristics of the Nipah virus glycoproteins","volume":"1102","author":"Diederich","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2026.07.031_bib106","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.ppat.0020007","article-title":"Two Key Residues in EphrinB3 Are Critical for Its Use as an Alternative Receptor for Nipah Virus","volume":"2","author":"Negrete","year":"2006","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2026.07.031_bib107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature03838","article-title":"EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus","volume":"436","author":"Negrete","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.07.031_bib108","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1743-422X-7-312","article-title":"A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System","volume":"7","author":"Khetawat","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.ymthe.2026.07.031_bib109","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.02032-12","article-title":"Nipah Virus Envelope-Pseudotyped Lentiviruses Efficiently Target ephrinB2-Positive Stem Cell Populations In Vitro and Bypass the Liver Sink When Administered In Vivo","volume":"87","author":"Palomares","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/viro.1999.9693","article-title":"Isolation and Molecular Characterization of a Novel Cytopathogenic Paramyxovirus from Tree Shrews","volume":"258","author":"Tidona","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib111","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1099\/jgv.0.000887","article-title":"A Tupaia paramyxovirus vector system for targeting and transgene expression","volume":"98","author":"Engeland","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib112","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1128\/jvi.66.8.4992-5001.1992","article-title":"High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells","volume":"66","author":"Wang","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib113","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1128\/JVI.73.10.8476-8484.1999","article-title":"Low-pH-Dependent Fusion of Sindbis Virus with Receptor-Free Cholesterol-and Sphingolipid-Containing Liposomes","volume":"73","author":"Smit","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib114","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1128\/JVI.00435-10","article-title":"Redirecting Lentiviral Vectors Pseudotyped with Sindbis Virus-Derived Envelope Proteins to DC-SIGN by Modification of N-Linked Glycans of Envelope Proteins","volume":"84","author":"Morizono","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood.2024024523","article-title":"In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand","volume":"144","author":"Nicolai","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.031_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002737","article-title":"Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells","volume":"9","author":"Huckaby","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.07.031_bib117","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib118","article-title":"In vivo production of CAR T cell: Opportunities and challenges","volume":"12","author":"Song","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.ymthe.2026.07.031_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105266","article-title":"Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment","volume":"106","author":"Bui","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.07.031_bib120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41587-026-03069-5","article-title":"B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?","volume":"44","author":"Senior","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib121","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib122","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib123","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/mto.2016.10","article-title":"LV305, a dendritic cell-targeting integration-deficient ZVex TM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response","volume":"3","author":"Albershardt","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2026.07.031_bib124","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/JVI.01289-07","article-title":"Immunization with a Lentivector That Targets Tumor Antigen Expression to Dendritic Cells Induces Potent CD8 + and CD4 + T-Cell Responses","volume":"82","author":"Lopes","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CJI.0000000000000183","article-title":"First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient","volume":"40","author":"Pollack","year":"2017","journal-title":"J. Immunother."},{"key":"10.1016\/j.ymthe.2026.07.031_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29452-0","article-title":"Durable targeting of B-lymphocytes in living mice","volume":"8","author":"Cascalho","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.031_bib127","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03187-1","article-title":"Engineering of \u03b1-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.07.031_bib128","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.ymthe.2021.09.019","article-title":"Genome edited B cells: a new frontier in immune cell therapies","volume":"29","author":"Rogers","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib129","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.ymthe.2023.08.012","article-title":"Advancing in vivo genome editing: B cell engineering via adenoviral delivery systems","volume":"31","author":"Cadinanos-Garai","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.omtm.2023.02.005","article-title":"The unknown impact of conditioning on HSC engraftment and clonal dynamics","volume":"28","author":"Radtke","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib131","doi-asserted-by":"crossref","first-page":"104752","DOI":"10.1016\/j.exphem.2025.104752","article-title":"Advantages and challenges of ex vivo generation and expansion of human hematopoietic stem cells from pluripotent stem cells","volume":"145","author":"Ding","year":"2025","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib132","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41577-022-00698-0","article-title":"Immunological barriers to haematopoietic stem cell gene therapy","volume":"22","author":"Charlesworth","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib133","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","article-title":"Current Concepts and Advances in Graft-Versus-Host Disease Immunology","volume":"39","author":"Hill","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib134","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/10430349950018625","article-title":"Targeting Retroviral Vectors to CD34-Expressing Cells: Binding to CD34 Does Not Catalyze Virus-Cell Fusion","volume":"10","author":"Benedict","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298542","article-title":"Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1","volume":"19","author":"Beschorner","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.07.031_bib136","article-title":"Treatment of infectious diseases by in vivo gene editing","volume":"2","author":"Wu","year":"2023","journal-title":"Natl. Sci. Open"},{"key":"10.1016\/j.ymthe.2026.07.031_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2026.106355","article-title":"Overview of gene editing strategies against HBV","volume":"247","author":"Janetzki","year":"2026","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2026.07.031_bib138","doi-asserted-by":"crossref","first-page":"eabh1209","DOI":"10.1126\/scitranslmed.abh1209","article-title":"CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models","volume":"14","author":"Seif","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib139","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/TP.0000000000004175","article-title":"Delivering siRNA Compounds during HOPE to Modulate Organ Function: A Proof-of-concept Study in a Rat Liver Transplant Model","volume":"106","author":"Bonaccorsi-Riani","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2026.07.031_bib140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/hum.2018.117","article-title":"Immunoengineering of the Vascular Endothelium to Silence MHC Expression during Normothermic Ex Vivo Lung Perfusion","volume":"30","author":"Figueiredo","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib141","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157508","article-title":"Protection of the transplant kidney from preservation injury by inhibition of matrix metalloproteinases","volume":"11","author":"Moser","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.07.031_bib142","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jtcvs.2023.08.047","article-title":"Gene delivery followed by ex vivo lung perfusion using an adeno-associated viral vector in a rodent lung transplant model","volume":"167","author":"Gao","year":"2024","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ymthe.2026.07.031_bib143","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0000000000002515","article-title":"First Report of siRNA Uptake (for RNA Interference) during Ex Vivo Hypothermic and Normothermic Liver Machine Perfusion","volume":"103","author":"Gillooly","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ymthe.2026.07.031_bib144","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-5223(97)70006-0","article-title":"Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival","volume":"114","author":"Brauner","year":"1997","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ymthe.2026.07.031_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1272945","article-title":"Pushing the boundaries of innovation: the potential of ex vivo organ perfusion from an interdisciplinary point of view","volume":"10","author":"Iske","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib146","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jimd.12709","article-title":"Liver-directed gene therapy for inherited metabolic diseases","volume":"47","author":"Baruteau","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2026.07.031_bib147","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.gastro.2011.04.002","article-title":"Inflammation promotes the loss of adeno-associated virus-mediated transgene expression in mouse liver","volume":"141","author":"Breous","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.07.031_bib148","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2024.07.034","article-title":"Targeted gene therapy for rare genetic kidney diseases","volume":"106","author":"Khare","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.ymthe.2026.07.031_bib149","first-page":"1","article-title":"Advances in Gene Therapy for Respiratory and Renal Diseases","volume":"6","author":"Ferreira","year":"2025","journal-title":"J. Stem Cell Res. (Overl. Park)"},{"key":"10.1016\/j.ymthe.2026.07.031_bib150","first-page":"e471","article-title":"Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart Association","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2026.07.031_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101333","article-title":"Gene therapy and kidney diseases","volume":"32","author":"Tavakolidakhrabadi","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib152","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.ymthe.2025.03.041","article-title":"The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy","volume":"33","author":"Puzzo","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib153","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41575-022-00729-0","article-title":"Gene therapy for liver diseases\u2014progress and challenges","volume":"20","author":"Zabaleta","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib154","article-title":"Lentiviral vectors can be used for full-length dystrophin gene therapy","volume":"7","author":"Counsell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.07.031_bib155","article-title":"Delivery of genetic medicines for muscular dystrophies","volume":"6","author":"Chulanova","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib156","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.031_bib157","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/cells13070596","article-title":"Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy","volume":"13","author":"Sun","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.07.031_bib158","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cell.2023.03.033","article-title":"Enveloped viruses pseudotyped with mammalian myogenic cell fusogens target skeletal muscle for gene delivery","volume":"186","author":"Hindi","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.07.031_bib159","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40291-024-00759-1","article-title":"Inner Ear Gene Therapy: An Overview from Bench to Bedside","volume":"29","author":"Gadenstaetter","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib160","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.ymthe.2023.10.018","article-title":"Third-generation lentiviral gene therapy rescues function in a mouse model of Usher 1B","volume":"31","author":"Schott","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib161","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.ymthe.2025.03.029","article-title":"Combined AAV-mediated specific Gjb2 expression restores hearing in DFNB1 mouse models","volume":"33","author":"Sun","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib162","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306788","article-title":"AAV-Mediated Gene Therapy Restores Hearing in Patients with DFNB9 Deafness","volume":"11","author":"Qi","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.07.031_bib163","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semcdb.2013.03.009","article-title":"Inner ear supporting cells: Rethinking the silent majority","volume":"24","author":"Wan","year":"2013","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib164","first-page":"180","article-title":"Single-cell transcriptomic atlas of mouse cochlear aging","volume":"14","author":"Sun","year":"2023","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2026.07.031_bib165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00441-014-2029-z","article-title":"Connexins and gap junctions in the inner ear \u2013 it\u2019s not just about K+ recycling","volume":"360","author":"Jagger","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymthe.2026.07.031_bib166","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00439-016-1648-8","article-title":"Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss","volume":"135","author":"Sloan-Heggen","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2026.07.031_bib167","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/hmg\/ddv109","article-title":"Perinatal GJB2 gene transfer rescues hearing in a mouse model of hereditary deafness","volume":"24","author":"Iizuka","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.07.031_bib168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/gt.2013.59","article-title":"Virally expressed connexin26 restores gap junction function in the cochlea of conditional Gjb2 knockout mice","volume":"21","author":"Yu","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.07.031_bib169","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.omtm.2021.09.009","article-title":"GJB2 gene therapy and conditional deletion reveal developmental stage-dependent effects on inner ear structure and function","volume":"23","author":"Guo","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.07.031_bib170","series-title":"Neurobiology: Exploring the Brain","first-page":"344","article-title":"The Auditory and Vestibular Systems","author":"Bear","year":"2007"},{"key":"10.1016\/j.ymthe.2026.07.031_bib171","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.3390\/jcm14165661","article-title":"Genetic Therapies for Retinitis Pigmentosa: Current Breakthroughs and Future Directions","volume":"14","author":"Pniakowska","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib172","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/biom15070940","article-title":"Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions","volume":"15","author":"Huang","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2026.07.031_bib173","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/OPTH.S364200","article-title":"Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses","volume":"16","author":"Ghoraba","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2026.07.031_bib174","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/genes16070847","article-title":"Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions","volume":"16","author":"AlEissa","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2026.07.031_bib175","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In Vivo\u2013Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib176","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135112","article-title":"In vivo\u2013directed evolution of adeno-associated virus in the primate retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.07.031_bib177","first-page":"1269","article-title":"Identification of Cell Surface Markers Which Mark Subset of Retinal Cells","volume":"50","author":"Watanabe","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2026.07.031_bib178","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41467-020-15326-5","article-title":"Identification of cell surface markers and establishment of monolayer differentiation to retinal pigment epithelial cells","volume":"11","author":"Plaza Reyes","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.07.031_bib179","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(25)01030-X","article-title":"In-vivo B-cell maturation antigen CAR T-cell therapy for relapsed or refractory multiple myeloma","volume":"406","author":"Xu","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.07.031_bib180","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41591-026-04244-6","article-title":"In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study","volume":"32","author":"An","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.07.031_bib181","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2025-252","volume":"146","author":"Harrison","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.07.031_bib182","doi-asserted-by":"crossref","first-page":"1750.1","DOI":"10.1182\/blood-2024-208461","article-title":"A phase 1, Multicenter, Open-Label Study of UB-VV111 in Combination with Rapamycin in Relapsed\/Refractory CD19+ B-Cell Malignancies","volume":"144","author":"Garcia","year":"2024","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600599X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600599X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:35:14Z","timestamp":1793374514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600599X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":181,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S152500162600599X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.031","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing the package: Cell-specific gene delivery using lentiviral vectors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}